CHRISTIAN PENG
Partner·Beijing
CHRISTIAN PENG
Partner·Beijing
-
CHRISTIAN PENG
Partner·Beijing
PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading
Mr. Peng specializes iN M&A, private equity investment, foreign direct investment, outbound investment and general commercial matters.
Education
Peking University School of Law, LL.B, 2010
Peking University China Center for Economic Research, Bachelor of Economics, 2010
University of California, Berkeley, LL.M, 2011
Professional Qualification
Admitted to practice in the PRC and New York
Professional Background
Mr. Peng joined Fangda in 2015. Before joining the firm, he worked at another leading PRC law firm as an associate for three years and at a leading investment firm as legal director. He has been awarded as a top young lawyer (30 under 30) by LegalBand.
PROFILE
REPRESENTATIVE MATTERS AND CASES
- Represented Anta, FountainVest and other co-investors in their tender offer acquisition of Amer Sports for EUR 4.6 billion (Outbound Bound Deal of Year 2018, China Law & Practice)
- Represented Weichai Power in its acquisition of 25% shares in KION GmbH and 70% equity interest in Kion’s subsidiary, Linde Hydraulics, for USD 750 million (Outbound Bound Deal of Year 2012, China Law & Practice)
- Represented Zoomlion in its sale of Zoomlion Environment to a consortium for RMB 1.16 billion
- Represented Fosun Pharma in its privatization and delisting of Chindex (the holding entity for United Family Hospital) from the NASDAQ
- Represented ByteDance in its acquisition of a music company
- Represented Baring Asia and CITIC PE in its acquisition of 100% shares in Wall Street English for USD 300 million
- Represented Warburg Pincus in its equity investment into Ant Finance
- Represented CITIC PE in its acquisition of equity interest in ByteDance
- Represented Warburg Pincus and other investors in its sale of stocks in AANG (HK.2686) through a tender offer
- Represented Fosun Pharma in forming a consortium with other investors to acquire 100% shares of a leading pharmaceuticals company, Ambrx Inc. for USD 180 million
- Represented Zoomlion and Mandarin Capital in their acquisition of 75% shares of Ladurner
- Represented Shandong Heavy Industry Group in its acquisition of 75% shares of Italian luxury yacht manufacture Feretti S.p.A. for EUR 374 million
- Represented Guohua Energy Investment Co. in its acquisition of 75% shares of Musselroe Wind Farm in Australia
- Represented CVC Capital Partners in its acquisition of majority stake in South Beauty, a prominent full-service restaurant in China
- Represented Veolia in its acquisition of a biomass power station
- Represented Daimler AG on its pre-IPO investment for a 12% stake in BAIC Motor for RMB 5.13 billion
- Represented Nissan in the divesture of a commercial vehicle business from Dongfeng-Nissan
- Represented Qingdao Haier (SH.600690) in its issuance of 10% shares to KKR as a strategic partner through PIPE
- Represented Alibaba in its acquisition of a video game company
- Represented Boyu Capital in its equity investment into a top-tier liquor enterprise
- Represented Yunfeng Capital in its investments into startup companies
